Navigation Links
Angiotensin II RIA Hypertension / Cardiac Evaluation, Cardiovascular 001-RK-A22

ProductsAngiotensin II RIA Hypertension / Cardiac Evaluation, Cardiovascular 001-RK-A22
Company ALPCO Diagnostics
Item Angiotensin II RIA Hypertension / Cardiac Evaluation, Cardiovascular 001-RK-A22
Features 
Description Angiotensin II (Ang II) is the most potent pressure agent known to date and is the biologically active peptide of the renin-angiotensin system (RAS). The proteolytic enzyme renin, synthesized, stored and secreted primarily by the juxtaglomerular cells of the kidneys, cleaves angiotensinogen to produce the decapeptide angiotensin I (Ang I) which is physiologically inactive. Ang I is rapidly cleaved by the angiotensin converting enzyme (ACE) in plasma, vascular endothelial cells, kidney, lung and other tissues, into Ang II, the major active component of the renin-angiotensin cascade10, 11 (see fig.1). This octapeptide is then rapidly degraded by various angiotensinases (aminopeptidases) found in plasma and tissues to the heptapeptide Ang III and to its subsequent degradation products, the hexa-, penta- and tetrapeptides, 5,6,12,13 This assay measures Ang II by a double-antibody radioimmunoassay using a modification of the method by Emanuel et al. 1. Standards, controls and reversed phase-extracted plasma samples are incubated for 16 hours with anti-angiotensin II antibody; 125I-angiotensin II then competes with angiotensin II present in samples and standards for the same antibody binding sites. After a second 6-hour incubation, the solid-phase second antibody is added to the mixture, antibody-bound fraction is precipitated and counted.
Info ALPCO DiagnosticsCall ALPCO Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-466-7731

Customer Service: (800) 592-5726
Web site: http://www.alpco.com

Related medicine products :

1. ACE Kinetic Hypertension / Cardiac Evaluation, Cardiovascular 001-KK-ACK4 Angiotensin Converting Enzyme
2. ACE Kinetic Hypertension / Cardiac Evaluation, Cardiovascular 001-KK-ACK Angiotensin Converting Enzyme
3. ACE Kinetic Hypertension / Cardiac Evaluation, Cardiovascular 001-KK-ACKX Angiotensin Converting Enzyme
4. ACE - REA Hypertension / Cardiac Evaluation, Cardiovascular 001-RK-ACD Angiotensin Converting Enzyme
5. Angiotensin II
6. Angiotensin II EIA Kit
7. Angiotensin Converting Enzyme, CSF
8. Angiotensin Converting Enzyme, Serum
9. ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018
10. Troponin I EIA Hypertension/ Cardiac Evaluation 025-BC-1105
11. Cortisol EIA Hypertension / Cardiac Evaluation, Cardiovascular 012-MDKCO1 Stress Hormones
... The Hancock® II bioprosthesis ... 15 years of proven clinical ... that the freedom from structural ... aortic and mitral bioprostheses is ...
Attain Venogram Balloon Catheter....
... defibrillators are used to treat heart rhythms ... Implantable cardioverter defibrillators (ICDs) often are used ... have been found to reduce the SCD ... high as 55 percent to less than ...
... The AL-100 is designed for fast ... operator when the probe is aligned & ... to 10 readings, for use in the ... from 15-40mm with an accuracy of 0.1mm ...
Medicine Products:
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: